Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
Status:
Recruiting
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This study will attempt to demonstrate the efficacy of Sodium Thiosulfate (STS) in preventing
hearing loss in patients re-treated with cisplatin-based therapy according to regimens
Cisplatin and STS (regimen CS) and Cisplatin, STS and Vorinostat/SAHA (regimen CSS).